These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27110117)

  • 1. Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder.
    Medhasi S; Pasomsub E; Vanwong N; Ngamsamut N; Puangpetch A; Chamnanphon M; Hongkaew Y; Limsila P; Pinthong D; Sukasem C
    Neuropsychiatr Dis Treat; 2016; 12():843-51. PubMed ID: 27110117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.
    Jittikoon J; Mahasirimongkol S; Charoenyingwattana A; Chaikledkaew U; Tragulpiankit P; Mangmool S; Inunchot W; Somboonyosdes C; Wichukchinda N; Sawanpanyalert P; He Y; McLeod HL; Chantratita W
    J Hum Genet; 2016 Feb; 61(2):119-27. PubMed ID: 26423926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder.
    Hongkaew Y; Medhasi S; Pasomsub E; Ngamsamut N; Puangpetch A; Vanwong N; Chamnanphon M; Limsila P; Suthisisang C; Wilffert B; Sukasem C
    Pharmacogenomics J; 2018 Dec; 18(6):740-748. PubMed ID: 29955115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMET microarray technology for pharmacogenomics-based personalized medicine.
    Burmester JK; Sedova M; Shapero MH; Mansfield E
    Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients.
    Medhasi S; Pinthong D; Pasomsub E; Vanwong N; Ngamsamut N; Puangpetch A; Chamnanphon M; Hongkaew Y; Pratoomwun J; Limsila P; Sukasem C
    Front Pharmacol; 2016; 7():475. PubMed ID: 28018217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
    Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
    Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment.
    Yi S; An H; Lee H; Lee S; Ieiri I; Lee Y; Cho JY; Hirota T; Fukae M; Yoshida K; Nagatsuka S; Kimura M; Irie S; Sugiyama Y; Shin DW; Lim KS; Chung JY; Yu KS; Jang IJ
    Pharmacogenet Genomics; 2014 Oct; 24(10):477-85. PubMed ID: 25029633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia.
    Vanwong N; Tipnoppanon S; Na Nakorn C; Srisawasdi P; Rodcharoen P; Medhasi S; Chariyavilaskul P; Siwamogsatham S; Vorasettakarnkij Y; Sukasem C
    Pharmgenomics Pers Med; 2022; 15():119-130. PubMed ID: 35210819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population.
    Tayeb HT; Bakheet DH; Zaza K; Wakil SM; Dzimiri N
    J Pharm Pharmacol; 2015 Jul; 67(7):972-9. PubMed ID: 25684066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore.
    Chowbay B; Zhou S; Lee EJ
    Drug Metab Rev; 2005; 37(2):327-78. PubMed ID: 15931768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.
    Arici M; Özhan G
    Saudi Pharm J; 2017 Mar; 25(3):376-380. PubMed ID: 28344492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.
    Kim B; Yoon DY; Lee S; Jang IJ; Yu KS; Cho JY; Oh J
    Transl Clin Pharmacol; 2021 Sep; 29(3):135-149. PubMed ID: 34621706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMET-Miner: Efficient discovery of association rules from pharmacogenomic data.
    Agapito G; Guzzi PH; Cannataro M
    J Biomed Inform; 2015 Aug; 56():273-83. PubMed ID: 26092773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
    Lubomirov R; di Iulio J; Fayet A; Colombo S; Martinez R; Marzolini C; Furrer H; Vernazza P; Calmy A; Cavassini M; Ledergerber B; Rentsch K; Descombes P; Buclin T; Decosterd LA; Csajka C; Telenti A;
    Pharmacogenet Genomics; 2010 Apr; 20(4):217-30. PubMed ID: 20139798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.
    Wakil SM; Nguyen C; Muiya NP; Andres E; Lykowska-Tarnowska A; Baz B; Tahir AI; Meyer BF; Morahan G; Dzimiri N
    Dis Markers; 2015; 2015():542543. PubMed ID: 25802476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.
    Fernandez CA; Smith C; Yang W; Lorier R; Crews KR; Kornegay N; Hicks JK; Stewart CF; Kawedia JD; Ramsey LB; Liu C; Evans WE; Relling MV; Broeckel U
    Clin Pharmacol Ther; 2012 Sep; 92(3):360-5. PubMed ID: 22871999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment.
    Charoenchokthavee W; Panomvana D; Sriuranpong V; Areepium N
    Breast Cancer (Dove Med Press); 2016; 8():149-55. PubMed ID: 27540311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DMET-analyzer: automatic analysis of Affymetrix DMET data.
    Guzzi PH; Agapito G; Di Martino MT; Arbitrio M; Tassone P; Tagliaferri P; Cannataro M
    BMC Bioinformatics; 2012 Oct; 13():258. PubMed ID: 23035929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders.
    Sukasem C; Hongkaew Y; Ngamsamut N; Puangpetch A; Vanwong N; Chamnanphon M; Chamkrachchangpada B; Sinrachatanant A; Limsila P
    J Clin Psychopharmacol; 2016 Apr; 36(2):141-6. PubMed ID: 26872113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.